AltruBio Announces Completion of Enrollment in Phase 1
SAN FRANCISCO, May 12, 2022 (GLOBE NEWSWIRE) -- AltruBio Inc. (“AltruBio” or “the Company”), a clinical stage biotech company dedicated to the development of novel therapeutics for the treatment of ...